199 related articles for article (PubMed ID: 37368186)
1. Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes.
Song Z; Lin S; Wu X; Ren X; Wu Y; Wen H; Qian B; Lin H; Huang Y; Zhao C; Wang N; Huang Y; Peng B; Li X; Peng H; Shen S
Hepatol Int; 2023 Oct; 17(5):1300-1317. PubMed ID: 37368186
[TBL] [Abstract][Full Text] [Related]
2. Occult hepatitis B virus infection in Chinese cryptogenic intrahepatic cholangiocarcinoma patient population.
Li Y; Wang H; Li D; Hu J; Wang H; Zhou D; Li Q; Jiang X; Zhou H; Hu H
J Clin Gastroenterol; 2014; 48(10):878-82. PubMed ID: 24356457
[TBL] [Abstract][Full Text] [Related]
3. HBV infection effects prognosis and activates the immune response in intrahepatic cholangiocarcinoma.
Li Z; Gao Q; Wu Y; Ma X; Wu F; Luan S; Chen S; Shao S; Shen Y; Zhang D; Feng F; Yuan L; Wei S
Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38206204
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.
Zhou HB; Wang H; Li YQ; Li SX; Wang H; Zhou DX; Tu QQ; Wang Q; Zou SS; Wu MC; Hu HP
World J Gastroenterol; 2011 Mar; 17(10):1292-303. PubMed ID: 21455328
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus is associated with the clinical features and survival rate of patients with intrahepatic cholangiocarcinoma.
Tao LY; He XD; Xiu DR
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):682-687. PubMed ID: 27282820
[TBL] [Abstract][Full Text] [Related]
6. Isolated anti-HBc is an independent risk factor for tumor recurrence in intrahepatic cholangiocarcinoma after curative resection.
Xu XB; Hu C; Yang HJ; Zheng SS
Hepatobiliary Pancreat Dis Int; 2022 Oct; 21(5):472-478. PubMed ID: 35948505
[TBL] [Abstract][Full Text] [Related]
7. HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature.
Wang C; Jing H; Sha D; Wang W; Chen J; Cui Y; Han J
BMC Infect Dis; 2016 Jun; 16():295. PubMed ID: 27301956
[TBL] [Abstract][Full Text] [Related]
8. Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma.
Zhao L; Wang Y; Tian T; Rao X; Dong W; Zhang J; Yang Y; Tao Q; Peng F; Shen C; Wang S; Liu H; Zeng X; Zhou W
Hepatol Int; 2022 Dec; 16(6):1339-1352. PubMed ID: 36123506
[TBL] [Abstract][Full Text] [Related]
9. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma.
Zhang L; Cai JQ; Zhao JJ; Bi XY; Tan XG; Yan T; Li C; Zhao P
J Surg Oncol; 2010 Mar; 101(3):233-8. PubMed ID: 20169539
[TBL] [Abstract][Full Text] [Related]
10. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma.
Seo JW; Kwan BS; Cheon YK; Lee TY; Shim CS; Kwon SY; Choe WH; Yoo BC; Yoon JM; Lee JH
Korean J Intern Med; 2020 May; 35(3):566-573. PubMed ID: 31916422
[TBL] [Abstract][Full Text] [Related]
12. Detection of hepatitis B virus DNA in paraffin-embedded intrahepatic and extrahepatic cholangiocarcinoma tissue in the northern Chinese population.
Wu Y; Wang T; Ye S; Zhao R; Bai X; Wu Y; Abe K; Jin X
Hum Pathol; 2012 Jan; 43(1):56-61. PubMed ID: 21777950
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma.
Matsumoto K; Onoyama T; Kawata S; Takeda Y; Harada K; Ikebuchi Y; Ueki M; Miura N; Yashima K; Koda M; Sakamoto T; Endo M; Horie Y; Murawaki Y
Intern Med; 2014; 53(7):651-4. PubMed ID: 24694471
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus and intrahepatic cholangiocarcinoma.
Gatselis NK; Tepetes K; Loukopoulos A; Vasiou K; Zafiriou A; Gioti C; Dalekos GN
Cancer Invest; 2007 Feb; 25(1):55-8. PubMed ID: 17364558
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Jeong S; Tong Y; Sha M; Gu J; Xia Q
Oncotarget; 2017 Mar; 8(10):17292-17300. PubMed ID: 28030846
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma.
Ahn CS; Hwang S; Lee YJ; Kim KH; Moon DB; Ha TY; Song GW; Lee SG
ANZ J Surg; 2018 Mar; 88(3):212-217. PubMed ID: 27598539
[TBL] [Abstract][Full Text] [Related]
18. [Affects of HBV genotypes (B/C) on the levels of serum and intrahepatic HBsAg].
Chen JJ; Ma SW; Wang ZH; Sun J; Zhu YF; Hou JL
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1947-51. PubMed ID: 17064586
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus infection and intrahepatic cholangiocarcinoma.
Zhou HB; Hu JY; Hu HP
World J Gastroenterol; 2014 May; 20(19):5721-9. PubMed ID: 24914333
[TBL] [Abstract][Full Text] [Related]
20. Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection.
Lei Z; Xia Y; Si A; Wang K; Li J; Yan Z; Yang T; Wu D; Wan X; Zhou W; Liu J; Wang H; Cong W; Wu M; Pawlik TM; Lau WY; Shen F
J Hepatol; 2018 Apr; 68(4):655-662. PubMed ID: 29155069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
